Упрощенная HTML-версия
the risk of cerebrovascular accident / A. Fournier [et al.] // Arch. Mal. Coeur
Vaiss. – 1999. – Vol. 92, № 8. – P. 997-1000.
240.
Decreased peripheral blood flow in the pathogenesis of the metabolic
syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia / L.
Lind [et al.] // Am. Heart J. – 1993. – Vol. 125. – P. 1494-1497.
241.
Definition of metabolic syndrome: report of the National Heart, Lung, and
Blood Institute. American Heart Association conference on scientific issues
related to definition / S. M. Grundy [et al.] // Circulation. – 2004. – № 109. – P.
433-438.
242.
Desmond D. Vascular dementia / D. Desmond // Clin Neurosci Res. – 2004. –
N 3. – Р. 437-448.
243.
DiBona G. F. The sympathetic nervous system and hypertension / G.F. DiBona
// Hypertension. - 2004. – Vol. 43, № 2. – P. 147 – 150.
244.
Discrimination between alphaz-adrenoceptors and [3H]idazoxan-labelled
nonadrenergic sites in rabbit white fat cells / D. Langin [et al.] // Eur. J.
Pharmacol. – 1990. – Vol. 188. – P. 261-272.
245.
Dislipidemias and fibrinolisis / L. Puccetti [et al.] // Ital. Heart J. – 2002. –
Vol.3. – P. 579-586.
246.
Dissociation between muscle and skin sympathetic activity in essential
hypertension, obesity, and congestive heart failure / G. Grassi [et al.] //
Hypertension. – 1998. – Vol. 31. – P. 64-67.
247.
Does hypertension confer a hypercoagulable state? / G.Y. Lip [et al.] //
Hypertens. – 1998. – №16. – P.913-916.
248.
Dose relation of blood pressure reduction with Moxonidine: Findings from
three placeboand active-controlled randomized studies / B. N. C. Prichard [et
al.] // J. Clin. Basic Cardiol. – 2003. – Vol. 6. – P. 49–51.
249.
Dow R. S. Cerebellar cognition / R. S. Dow // Neurology. – 1995. – V. 45. – Р.
1785-1786.